Journal of Clinical Epidemiology
Volume 54, Issue 5 , Pages 448-461 , May 2001

A comparative meta-analysis on the variability in test performance among FDA-licensed enzyme immunosorbent assays for HIV antibody testing

  • J. Kowalski

      Affiliations

    • Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115 USA
    • Corresponding Author InformationCorresponding author
    • ,
  • X.M. Tu

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania Medical Center, 423 Guardian Drive, Philadelphia, PA 19104-6021 USA
    • ,
  • G. Jia

      Affiliations

    • Cleveland Clinic Cardiovascular Coordinating Center, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 USA
    • ,
  • M. Pagano

      Affiliations

    • Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115 USA

Received 17 November 1997 ,Revised 7 August 2000 ,Accepted 8 August 2000.

References 

  1. Lopez M, Fleisher T, deShazo RD. Use and interpretation of diagnostic immunologic laboratory tests. JAMA. 1992;268:2970–2990
  2. Schwartz JS, Dans PE, Kinosian BP. Human Immunodeficiency Virus test evaluation, performance, and use. JAMA. 1988;259:2574–2579
  3. Hancock JS, Taylor RN, Johnson CA, Gerber AR, Schalla WO. Quality of laboratory performance in testing for Human Immunodeficiency Virus Type I antibody (identification of variables associated with laboratory performance). Arch Pathol Lab Med. 1993;117:1148–1155
  4. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando, FL: Academic Press; 1985;
  5. Phillips KA. The use of meta-analysis in technology assessment (a meta-analysis of the enzyme immunosorbent assay Human Immunodeficiency Virus antibody test). J Clin Epidemiol. 1991;44:925–931
  6. Owens DK, Holodniy M, McDonald TW, Scott J, Sonnad S. A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants. JAMA. 1996;275(17):1342–1348
  7. Iyengar S, Greenhouse JB. Selection models and the file drawer problem. Stat Sci. 1988;3:109–135
  8. Denis F, Leonard G, Mounier M, Sangare A, Gershy-Damet G, Rey JL. Efficacy of five enzyme immunoassays for antibody to HIV in detecting antibody to HTLV-IV. Lancet 1987:324–5.
  9. Taylor RN, Przybyszewski VA. Summary of the Centers for Disease Control Human Immunodefficiency Virus (HIV) performance evaluation surveys for 1985 and 1986. Am J Clin Pathol. 1988;89:1–13
  10. Centers for Disease Control . Update (Serologic Testing for Antibody to Human Immunodeficiency Virus). MMWR. 1988;36:833–840
  11. Cross GD, Schalla WO, Hancock JS, Hearn TL, Blumer SO, Taylor RN, et al.  Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus Type 1 antibody. Arch Pathol Lab Med. 1992;116:477–481
  12. Taylor RN, Hearn TL, Schalla WO, Valdiserri RO. Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control model performance evaluation program for Human Immunodeficiency Virus Type 1 testing. J Clin Microbiol. 1990;28:1799–1807
  13. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology. 2nd. ed. Baltimore, MD: Williams and Wilkins, 1988.
  14. Tu XM, Litvak E, Pagano M. Issues in HIV screening programs. Am J Epidemiol. 1992;136:244–255
  15. Reid M, Lachs M. Feinstein A. Use of methodological standards in diagnostic test research. JAMA. 1995;274:645–651
  16. Irwig LM, Tosteson A, Gatsonis C, Lau J, Colditz G, Chalmers TC, et al.  Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994;120:667–677
  17. Cooper LS, Chalmers TC, McCally M, Berrier J, Sacks HS. The poor quality of early evaluations of magnetic resonance imaging. JAMA. 1988;259:3277–3280
  18. Rosenthal MC. The fugitive literature. In:  Cooper H,  Hedges LV editor. The handbook of research synthesis. New York: Russell Sage Foundation; 1994;p. 85–94
  19. Medical economics. Montvale, NJ. Medical Device Register, 1995.
  20. Denis F, Leonard G, Sangare A, Gershy-Damet G, Rey JL, Soro B, et al.  Comparison of 10 enzyme immunoassays for detection of antibody to Human Immunodeficiency Virus type 2 in West African Sera. J Clin Microbiol. 1988;26:1000–1004
  21. Van Kerckhoven I, Vercauteren G, Piot P, Van der Groen G. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull WHO. 1991;69:753–760
  22. Constantine NT, Callahan JD, Watts DM. Retroviral testing essentials for quality control and laboratory diagnosis. Boca Raton, FL: CRC Press; 1991;
  23. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press; 1996;
  24. Agresti A. Categorical data analysis. NY: Wiley; 1990;
  25. Kowalski J, Tu XM. GEE and GLMM approaches for modeling correlated meta-analytic data. Technical Report, Department of Biostatistics, Harvard School of Public Health, Boston, MA (2000).
  26. SAS Institute Inc . SAS/STAT software (changes and enhancements through release 6.12). Cary, NC: SAS Institute Inc; 1997;
  27. Herberman RB. Sources of confounding immunologic data. RID. 1991;Suppl 1)13:S84–S86
  28. O'Brien TR, George JR, Holmberg SD. Human Immunodeficiency Virus Type 2 infection in the United States (epidemiology, diagnosis, and public health implications). JAMA. 1992;267:2775–2779
  29. Chew V. Point estimation of the parameter of the binomial distribution. Am Stat. 1971;25:47–50
  30. Moses L, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve (data-analytic approaches and some additional considerations). Stat Med. 1993;12:1293–1316
  31. Gastwirth JL. The statistical precision of medical screening procedures (applications to polygraph and AIDS antibodies test data). Stat Sci. 1987;2:213–238
  32. Tu XM, Litvak E, Pagano M. On the informativeness and accuracy of pooled testing in estimating prevalence for a rare disease (application to HIV screening). Biometrika. 1995;82:287–297
  33. Mendoza-Blanco JR, Tu XM, Iyengar S. Bayesian inference on prevalence using a missing-data approach with simulation-based techniques (applications to HIV screening). Stat Med. 1996;15:2161–2176
  34. Tu XM, Kowalski J, Jia G. Bayesian analysis of prevalence with covariates using simulation-based techniques (applications to HIV screening). Stat Med. 1999;18:3059–3073
  35. Archbold E, Mitchell S, Hanson D, Hull B, Galo LM, Monzon O. Serum-pooling strategies for HIV screening (experiences in Dominican Republic, Trinidad, Ecuador, and the Philippines). Int Conf AIDS. 1991;7:331
  36. Azevedo-Pereira JM, Lourenco MH, Barin F, Cisterna R, Denis F, Moncharmont P, et al.  Multicenter evaluation of a fully automated screening test, VIDAS HIV 1+2, for antibodies to Human Immunodeficiency Virus Types 1 and 2. J Clin Microbiol. 1994;32:2559–2563
  37. Carlson JR, Hinrichs SH, Yee J, Gardner MB, Pedersen NC. Evaluation of three commercial screening tests for AIDS virus antibodies. AJCP. 1986;20:357–359
  38. Constantine NT, Fox E, Abbatte EA, Woody JN. Diagnostic usefulness of five screening assays for HIV in an East African city where prevalence of infection is low. AIDS. 1989;3:313–317
  39. Fang CT, Darr F, Kleinman S, Dood RY. Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western Blotting. Transfusion. 1986;26:208–209
  40. Farzadegan H, Taylor E, Hardy W, Odaka N, Polk BF. Performance of serological assays for early detection of Human Immunodeficiency Virus Type I seroconversion. J Clin Microbiol. 1989;27:1882–1884
  41. George JR, Rayfield M, Schochetman G, Heyward W, Odehouri K, Soudrey R. Sensitivity of U.S. FDA licensed HIV-1 enzyme immunoassays for detection of HIV-2 antibodies. Int Conf AIDS 1989;5:306.
  42. Holland PV, Richards CA, Teghtmeyer JR, Douville CM, Carlson JR, Hinrichs SH, et al.  Anti-HTLV-III testing of blood donors (reproducibility and confirmability of commercial test kits). Transfusion. 1985;25:395–397
  43. Jongerius JM, Van der Poel CL, Van Loon AM, Van den Akker R, Schaasberg W, van Leeuwen EF. Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O. Transfusion. 1997;37:841–844
  44. Leeds FA, Garstecki TM, Sautter RL. Comparison of the single use diagnostic system (SUDS) for the determination of HIV-1 antibody. ASCP/CAP Nat Mg. Washington, D.C., 1994.
  45. Maskill WJ, Crofts N, Waldman E, Healey DS, Howard TS, Silvester C, et al.  An evaluation of competitive and second generation ELISA screening tests for antibody to HIV. J Virol Methods. 1988;22:61–73
  46. Matter L, Germann D. Detection of Human Immunodeficiency Virus (HIV) Type 1 antibodies by new automated microparticle enzyme immunoassays for HIV Types 1 and 2. J Clin Microbiol. 1995;33:2338–2341
  47. Reesink HW, Lelie PN, Huisman JG, Schaasberg W, Gonsalves M, Aaij C, et al. Evaluation of six enzyme immunoassays for antibody against Human Immunodeficiency Virus. Lancet 1986:483–6.
  48. Silvester C, Healey DS, Cunningham P, Dax EM. Multisite evaluation of four Anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods. 1995;8:411–419
  49. Urassa WK, Bredberg-Raden U, Mbena E, Palsson K, Minja E, Lema RA, et al.  Alternative confirmatory strategies in HIV-1 antibody testing. JAIDS. 1992;5:170–176
  50. Van der Groen G, Van Kerckhoven I, Vercauteren G, Piot P. Simplified and less expensive confirmatory HIV testing. Bull WHO. 1991;69:747–752
  51. Vercauteren G, Beelaert G, Van der Groen G. Evaluation of an aggultination HIV-1+2 antibody assay. J Virol Methods. 1995;51:1–8
  52. Weber B, Hess G, Koberstein R, Doerr HW. Evaluation of the automated enzymen-test anti HIV-1+2 and enzymen-test Anti HIV-1/2 selective for the combined detection and differentiation of anti-HIV-1 and anti-HIV-2 antibodies. J Virol Methods. 1993;44:251–260
  53. Weber B, Moshtaghi-Boronjeni M, Brunner M, Preiser W, Breiner M, Doerr HW. Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods. 1995;55:97–104

PII: S0895-4356(00)00320-6

Journal of Clinical Epidemiology
Volume 54, Issue 5 , Pages 448-461 , May 2001

Article Tools

* Image Usage & Resolution